“…AVUS has been demonstrated preclinically in a range of tissue types 33 , 34 , 32 , 35 , 36 , 29 , 37 and has potential for applications where tissue destruction is desirable, such as in selected brain regions or tumors, the latter being of interest in the present study. While AVUS has demonstrated tumor growth inhibition on its own, the most profound antitumor effects are elicited when combining with conventional approaches of chemotherapy 38 , 15 , 39 , 40 , antiangiogenic strategies 41 , 42 , 31 , immunotherapy 43 , and radiotherapy 44 , 45 , 46 , 47 , 48 , 49 .…”